コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 sphorylation of the carboxyl terminus of the TXA2 receptor.
2 ng to the third intracytoplasmic loop of the TXA2 receptor.
3 ssion (Bmax = 95 +/- 6 pmol/mg) of the C-His-TxA2 receptors.
4 y different from those of the wild type (wt)-TxA2 receptors.
5 ficantly different between C-His-TxA2 and wt-TxA2 receptors.
6 ased structure-function and other studies of TxA2 receptors.
7 y another G-protein associated with platelet TXA2 receptors.
8 ligand and immunoaffinity chromatography, 2) TXA2 receptor activation stimulates GTPgammaS binding to
9 separate experiments, it was found that the TXA2 receptor agonist U46619 stimulated [35S]guanosine 5
10 ed as potent dual-acting agents to block the TXA2 receptor and to inhibit the thromboxane synthase (T
11 ation of a high level of expression of C-His-TxA2 receptors and a rapid purification procedure follow
12 haq and Galpha13 are functionally coupled to TXA2 receptors and dissociate upon agonist activation.
13 (C-His) was ligated to the alpha-isoform of TxA2 receptors and expressed in COS-7 and Chinese hamste
14 upled agonist receptors, the thromboxane A2 (TXA2) receptor, and protease-activated receptors (PARs).
18 lets deficient in PLC gamma 2, G alpha q, or TxA2 receptors, as well as platelets treated with a prot
21 affinity methods, in vivo phosphorylation of TXA2 receptors by cyclic GMP was demonstrated from 32P-l
22 that in addition to Galphaq, purification of TXA2 receptors by ligand (SQ31,491)-affinity chromatogra
23 o Galpha13, and 3) Galpha13 affinity for the TXA2 receptor can be modulated by agonist-receptor activ
24 irect evidence that endogenous Galpha13 is a TXA2 receptor-coupled G-protein, as: 1) its alpha-subuni
25 de mapping studies of in vivo phosphorylated TXA2 receptors demonstrated cGMP mediates phosphorylatio
30 to catalyze the phosphorylation of platelet TXA2 receptors in vitro, but not Galphaq copurifying wit
31 he relationship of structure to function for TxA2 receptors is limited because of their low levels of
33 ism of purinergic receptors (suramin+RB2) or TXA2 receptor (SQ29548), or by intratracheal apyrase.
34 r thromboxane A2 (TxA2), we created a mutant TxA2 receptor (TP receptor) in which serines at position
39 S18886 is an orally active thromboxane A2 (TXA2) receptor (TP) antagonist in clinical development f
42 r evidence for functional coupling of G13 to TXA2 receptors was provided in studies where solubilized
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。